The use of the information in the pharmaceutical industry. II. Results of a survey.
DOI:
https://doi.org/10.3989/redc.2000.v23.i2.322Keywords:
studies on users, information needs and habits, use of information, biblionletrics, pharmaceutical industry, questionnaireAbstract
Continuing with the study of information consumption in the pharmaceutical industry, this article describes the main results of the statistical analysis of the data obtained with a questionnaire completed by the pharmaceutical laboratories in the Madrid Region, in order to gather data on the information needs and habits of this industrial sector. In order to prepare the statistical study, typologies were established for those who completed the questionnaire and for companies, applying different parameters, such as the main activity carried on in the Madrid Region, the companies' headcount, their nationalities or the use of information services.
Downloads
Download data is not yet available.
Downloads
Published
2000-06-30
How to Cite
Ordóñez Vergara, M. J. (2000). The use of the information in the pharmaceutical industry. II. Results of a survey. Revista Española De Documentación Científica, 23(2), 179–196. https://doi.org/10.3989/redc.2000.v23.i2.322
Issue
Section
Studies
License
Copyright (c) 2000 Consejo Superior de Investigaciones Científicas (CSIC)
This work is licensed under a Creative Commons Attribution 4.0 International License.
© CSIC. Manuscripts published in both the printed and online versions of this Journal are the property of Consejo Superior de Investigaciones Científicas, and quoting this source is a requirement for any partial or full reproduction.All contents of this electronic edition, except where otherwise noted, are distributed under a “Creative Commons Attribution 4.0 International” (CC BY 4.0) License. You may read here the basic information and the legal text of the license. The indication of the CC BY 4.0 License must be expressly stated in this way when necessary.
Self-archiving in repositories, personal webpages or similar, of any version other than the published by the Editor, is not allowed.